Timothy M. Wright

Timothy M.
Wright is currently the Chairman at Kling Biotherapeutics BV, an Independent Director at ENYO Pharma SA, a Member-Supervisory Board at CureVac SE, and a General Partner at Time Bioventures.
Previously, he served as the Chief Executive Officer & Director at CS Genetics Ltd., an Independent Director at Schrödinger, Inc., a Senior Director-Clinical Sciences at Pfizer GmbH, an Assistant Professor at the University of Pittsburgh Medical Center, the Global Head-Pharma Development at Novartis Pharmaceuticals Corp., the Chief Research & Development Officer at Regulus Therapeutics, Inc., an Assistant Professor at The Johns Hopkins University School of Medicine, the Executive Vice President-Translational Sciences at California Institute for Biomedical Research, and a Member-Supervisory Board at CureVac NV.
Dr. Wright obtained his undergraduate degree from the University of Delaware in 1975 and his doctorate degree from The Johns Hopkins University School of Medicine in 1980.